Sinus Dilation Devices Industry Overview

The global sinus dilation devices market size was valued at USD 2.74 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 9.6% from 2023 to 2030.

The high preference for minimally invasive procedures, favorable reimbursement scenarios, rising awareness about the advantages of balloon sinuplasty over other conventional techniques, and the prevalence of chronic sinusitis are the major factors fostering the market growth. Developing advanced surgery techniques helps increase the market dynamics by replacing traditional procedures.

Gather more insights about the market drivers, restrains and growth of the Sinus Dilation Devices Market

Technological advancements, such as surgical laser technologies, in sinus surgery ensure minimal ablation and have fewer side effects. Decreased turnaround time enables these procedures to be performed in outpatient departments. For instance, in 2022, the National Health Service (NHS) introduced an innovative laser treatment for patients with epilepsy. This pioneering therapy utilizes lasers to target and treat areas of the brain that cause seizures, providing a new and advanced approach to managing epilepsy and improving patients' quality of life.

The COVID-19 pandemic led to interruptions in routine patient care. Many healthcare organizations have canceled routine clinic visits and elective surgeries to increase and maintain the availability of intensive care and inpatient care beds and have reorganized medical and nursing staff. This has particularly interrupted care for patients with chronic rhinitis. The patients opted for teleconsultations and temporary options for sinus-related problems.

For instance, in Canada, there was a significant decline in the number of surgeries during the first 31 months of the pandemic, amounting to approximately 937,000 fewer surgeries (14%) compared to the pre-pandemic period. These figures were determined by comparing the surgeries performed since March 2020 to a baseline of 2019 without considering population growth or other factors. The most substantial drop in surgeries occurred in the initial four months of the pandemic (March to June 2020), when many scheduled and non-urgent procedures were postponed or canceled across the country to align with public health guidelines.

Browse through Grand View Research's Medical Devices Industry Research Reports.

• The global embolic protection devices market size was valued at USD 612.9 million in 2023 and is projected to grow at a CAGR of 8.7% from 2024 to 2030.
• The global bone densitometers market size was valued at USD 241.2 million in 2023 and is projected to grow at a CAGR of 4.5% from 2024 to 2030.

Global Sinus Dilation Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global sinus dilation devices market based on product, type, procedure, application, end use, and region.

Product Outlook (Revenue in USD Million, 2018 - 2030)

• Ballon Sinus Dilation Devices
• Endoscopes 
• Sinus Stents/Implants 
• Functional Endoscopic Sinus Surgery (FESS) Instruments Set
• Others

Type Outlook (Revenue in USD Million, 2018 - 2030)

• Sinuscopes
• Rhinoscopes

Procedure Outlook (Revenue in USD Million, 2018 - 2030)

• Standalone
• Hybrid

Application Outlook (Revenue in USD Million, 2018 - 2030)

• Adult
• Pediatric

End-use Outlook (Revenue in USD Million, 2018 - 2030)

• Hospitals 
• Ambulatory Surgical Centers 
• ENT Clinics/In Office

Regional Outlook (Revenue in USD Million, 2018 - 2030)

• North America
  • US
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Key Companies Market Share Insights

Key players in the market are focusing on adopting growth strategies, such as mergers and acquisitions, developing existing devices, promotional events, and technological advancements. For instance, Intersect ENT, Inc., one of the leading medical technology companies for ear, nose, and throat care, introduced a new product in the U.S. called the Straight Delivery System (SDS) along with the PROPEL Mini Sinus Implant (a medical device). The U.S. Food and Drug Administration has approved this combined packaging, making it available for use. The Straight Delivery System was previously approved in July 2020. In simple terms, Intersect ENT has launched a new product in the U.S. that includes a medical device called the SDS and the PROPEL Mini Sinus Implant, which the FDA has approved for use:

• Medtronic
• Smith+Nephew
• Stryker
• Intersect ENT, Inc
• Olympus Corporation
• SinuSys Corporation
• Johnson Johnson Services, Inc.
• TE Connectivity
• InnAccel Technologies Pvt Ltd

Order a free sample PDF of the Sinus Dilation Devices Market Intelligence Study, published by Grand View Research.